Polypeptide fragments of hepatitis E virus, the vaccine comprising said fragments and the diagnostic kits
US7615228B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2001 |
| Grant date | Nov 10, 2009 |
| Priority date | — |
| Expiry date | Nov 6, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/28171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A purified polypeptide comprising the amino acid sequence as set forth in SEQ ID No. 1 of hepatitis E virus ORF 2 or its fragment, which is in the form of a polymer with n monomeric polypeptides, wherein n is an integer from 2-180; to a polypeptide of the present invention bound to a polypeptide containing epitope from hepatitis E virus ORF3or an immunogenic fragment thereof; to a recombinant expression vector comprising the DNA molecule encoding the above polypeptides and the host cell transformed with said recombinant expression vector which is able to express polypeptide of the present invention. The present invention further relates to a vaccine composition against hepatitis E virus which comprises the above-mentioned polypeptide, or diagnostic kit for hepatitis E virus infection comprising the above-mentioned polypeptide, which includes IgG, IgM, or total antibody diagnostic kit for hepatitis E virus, and to the use of vaccine composition and diagnostic kit for prophylaxis, diagnosis and/or treatment of hepatitis E virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.